Fund Holdings — BVF INC/IL

Total Portfolio Value:
$4.00B
Total Bought:
$466.53M
Total Sold:
$401.41M
Net Transaction:
+$65.13M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
MoonLake ImmunotherapeuticsCL A(MLTX)21,751,28421,751,2840$1.24B$1.31B32.87%+$73.74M
Revolution Medicines, Inc.(RVMD)3,981,2125,981,212+2,000,000$110.20M$171.54M4.29%+$61.34M
Axsome Therapeutics, Inc.(AXSM)2,131,1001,981,100-150,000$148.94M$157.68M3.95%+$8.73M
Protagonist Therapeutics Inc5,744,8485,744,8480$95.82M$131.73M3.30%+$35.91M
Kymera Therapeutics, Inc.(KYMR)4,739,0045,161,801+422,797$65.87M$131.42M3.29%+$65.55M
Mirum Pharmaceuticals, Inc.(MIRM)4,370,0244,370,0240$138.09M$129.00M3.23%-$9.09M
Olema Pharmaceuticals, Inc.(OLMA)9,135,8939,135,8930$112.83M$128.18M3.21%+$15.35M
Ionis Pharmaceuticals, Inc.(IONS)4,004,6132,428,613-1,576,000$181.65M$122.86M3.07%-$58.79M
Kura Oncology, Inc.(KURA)6,730,9837,373,228+642,245$61.39M$106.03M2.65%+$44.64M
4d Molecular Therapeutics In4,007,4134,007,4130$51.01M$81.19M2.03%+$30.18M
Lakefront Biotherapeutics NVADR(LKFT)1,915,1091,915,1090$66.17M$77.85M1.95%+$11.68M
Merus N V2,752,4202,752,4200$64.90M$75.69M1.89%+$10.79M
Repare Therapeutics Inc8,291,98810,333,600+2,041,612$100.17M$75.44M1.89%-$24.73M
AC Immune SASHS(ACIU)7,428,37914,571,236+7,142,857$21.17M$72.86M1.82%+$51.69M
Centessa Pharmaceuticals PlcADS9,103,0548,774,570-328,484$58.90M$69.85M1.75%+$10.95M
Xoma Corp Del3,633,7433,633,7430$51.20M$67.22M1.68%+$16.02M
IDEAYA Biosciences, Inc.(IDYA)5,283,4891,729,043-3,554,446$142.55M$61.52M1.54%-$81.03M
Zymeworks Inc.(ZYME)5,870,0005,870,0000$37.22M$60.99M1.53%+$23.77M
GH Research PLC(GHRS)9,275,15810,400,158+1,125,000$93.22M$60.32M1.51%-$32.89M
Essa Pharma Inc8,748,6298,748,6290$27.03M$57.74M1.45%+$30.71M
Janux Therapeutics, Inc.(JANX)4,579,8184,579,8180$46.16M$49.14M1.23%+$2.98M
Third Harmonic Bio Inc4,365,9334,365,9330$27.90M$47.89M1.20%+$20.00M
89bio Inc1,846,1544,047,354+2,201,200$28.50M$45.21M1.13%+$16.70M
Relay Therapeutics, Inc.(RLAY)2,365,8053,970,045+1,604,240$19.90M$43.71M1.09%+$23.81M
Xenon Pharmaceuticals Inc.(XENE)1,827,958890,072-937,886$62.44M$41.00M1.03%-$21.45M
Syndax Pharmaceuticals, Inc.(SNDX)01,875,000+1,875,000$0$40.52M1.01%+$40.52M
Tyra Biosciences, Inc.(TYRA)2,739,5952,739,5950$37.72M$37.94M0.95%+$219.2K
Lexicon Pharmaceuticals, Inc.(LXRX)19,995,33224,435,632+4,440,300$21.79M$37.39M0.94%+$15.59M
Structure Therapeutics IncADS1,750,000812,988-937,012$88.23M$33.14M0.83%-$55.10M
Cullinan Therapeutics, Inc.(CGEM)3,196,7013,196,7010$28.93M$32.57M0.82%+$3.64M
An2 Therapeutics Inc1,563,9631,563,9630$25.15M$32.05M0.80%+$6.90M
Annexon, Inc.(ANNX)07,000,000+7,000,000$0$31.78M0.80%+$31.78M
Roivant Sciences Ltd.SHS(ROIV)2,742,4092,742,4090$32.03M$30.80M0.77%-$1.23M
Silence Therapeutics plcADS(SLN)1,508,4161,508,4160$14.83M$26.20M0.66%+$11.37M
Allakos Inc8,552,4178,552,4170$19.41M$23.35M0.58%+$3.93M
Glycomimetics Inc9,544,2629,544,2620$14.32M$22.52M0.56%+$8.21M
Ovid Therapeutics Inc.(OVID)6,851,0516,851,0510$26.31M$22.06M0.55%-$4.25M
Engene Holdings Inc
COM
02,251,037+2,251,037$0$20.78M0.52%+$20.78M
Calliditas Therapeutics AbADS750,000750,0000$13.70M$19.33M0.48%+$5.63M
TScan Therapeutics, Inc.(TCRX)2,989,4742,989,4740$7.65M$17.43M0.44%+$9.78M
Newamsterdam Pharma Company
ORDINARY SHARES
1,521,9481,521,9480$14.08M$17.00M0.43%+$2.92M
Spyre Therapeutics, Inc.(SYRE)0687,080+687,080$0$14.79M0.37%+$14.79M
Sutro Biopharma, Inc.(STRO)3,347,9463,347,9460$11.62M$14.36M0.36%+$2.75M
Iteos Therapeutics Inc1,259,4761,259,4760$13.79M$13.79M0.35%$0
Verastem, Inc.(VSTM)1,685,2191,685,2190$13.70M$13.72M0.34%+$16.9K
Immunovant, Inc.(IMVT)300,000300,0000$11.52M$12.64M0.32%+$1.12M
Vistagen Therapeutics, Inc.(VTGN)02,000,000+2,000,000$0$10.28M0.26%+$10.28M
CytomX Therapeutics, Inc.(CTMX)6,595,8016,595,8010$8.51M$10.22M0.26%+$1.71M
Ikena Oncology Inc3,169,1644,769,164+1,600,000$13.72M$9.40M0.24%-$4.33M
Verve Therapeutics Inc650,000650,0000$8.62M$9.06M0.23%+$442.0K
Eledon Pharmaceuticals, Inc.(ELDN)4,326,7104,326,7100$5.93M$7.79M0.19%+$1.86M
SAB Biotherapeutics, Inc.(SABS)09,178,282+9,178,282$0$6.31M0.16%+$6.31M
Vigil Neuroscience Inc1,813,6331,813,6330$9.78M$6.13M0.15%-$3.65M
Cidara Therapeutics Inc6,861,1276,861,1270$6.46M$5.45M0.14%-$1.02M
Rain Oncology Inc3,526,7293,526,7290$3.04M$4.23M0.11%+$1.19M
Delcath Systems, Inc.(DCTH)976,149976,1490$3.95M$4.06M0.10%+$107.4K
Pieris Pharmaceuticals Inc20,609,86320,609,8630$6.14M$3.75M0.09%-$2.39M
Kronos Bio Inc2,905,0432,905,0430$3.78M$3.63M0.09%-$145.3K
Nls Pharmaceutics LtdSHS5,747,1265,747,1260$3.97M$3.39M0.08%-$580.5K
Inventiva S.A.ADS(IVA)686,040686,0400$2.88M$3.07M0.08%+$192.1K
Forte Biosciences Inc2,982,1052,982,1050$1.97M$2.45M0.06%+$476.2K
Corvus Pharmaceuticals, Inc.(CRVS)1,370,9471,370,9470$2.00M$2.41M0.06%+$411.3K
Viracta Therapeutics Inc3,614,6623,614,6620$3.76M$2.06M0.05%-$1.70M
Molecular Templates Inc532,038532,0380$3.36M$1.97M0.05%-$1.39M
Unicycive Therapeutics Inc3,413,5632,118,139-1,295,424$2.94M$1.84M0.05%-$1.10M
Molecular Partners AGADS(MOLN)443,221443,2210$1.77M$1.76M0.04%-$4.4K
Elevation Oncology Inc2,312,2002,312,2000$1.53M$1.24M0.03%-$290.4K
Engene Holdings IncW EXP 10 31 202
*W EXP 10/31/202
0945,402+945,402$0$803.6K0.02%+$803.6K
Aslan Pharmaceuticals LtdADS1,049,9991,049,9990$1.94M$548.2K0.01%-$1.39M
Rezolute, Inc.(RZLT)190,815190,8150$251.9K$189.4K0.00%-$62.5K
ACLARIS THERAPEUTICS INCCOM(ACRS)7,064,7360-7,064,736$48.39M$0—-$48.39M
BIONOMICS LIMITEDADS47,3720-47,372$127.9K$0—-$127.9K
IMMUNIC INCCOM(IMUX)1,149,4250-1,149,425$1.69M$0—-$1.69M
JASPER THERAPEUTICS INCCOM(JSPR)9,900,0000-9,900,000$6.93M$0—-$6.93M
POINT BIOPHARMA GLOBAL INCCOM10,563,7480-10,563,748$70.46M$0—-$70.46M
REPLIMUNE GROUP INCCOM(REPL)2,143,0360-2,143,036$36.67M$0—-$36.67M
Page 1 of 1
BVF INC/IL — 13F Holdings — Q4 2023 | TickerTrail